Cancer Patient Benefits from New Treatment at LB Memorial
2009-06-02 · By Editor
Breast cancer treatments have come a long way in recent decades. And Dr. John Link, Director of Long Beach Memorial Breast Center, has contributed to those advancements.
Dr. Link participated as an investigator in a national clinical trial for a new treatment regimen for early-stage breast cancer. Approved by the FDA in 2008, the new regimen reduces the rate of cardiac issues for women with HER2-positive early-stage breast cancer, an aggressive form of the disease which affects 25 percent of breast cancer patients.
Long Beach resident and breast cancer survivor Carla Copeland , age 44, is currently benefiting from this new treatment regimen. Carla was diagnosed with HER2-positive breast cancer in 2002; she is a competitive outrigger canoeist (see photo, 2nd from last) who participates in 12 races per year; she says canoeing helps her with the physical and mental coping of having cancer.